GSK-sponsored survey reveals unique gaps in care and support facing patients with gynaecologic cancers: London, UK Thursday, November 14, 2024, 15:00 Hrs [IST] GSK plc announced t ...
Researchers uncover new role of mutant proteins in some of the deadliest cancers: Maryland Thursday, November 14, 2024, 13:00 Hrs [IST] Researchers at the National Institutes of H ...
Ginkgo Bioworks advances collaboration with Merck to improve biologics manufacturing; Ginkgo to receive a research milestone payment of $9 million: Boston, Massachusetts Thursday, ...
As part of its commitment to the global initiative to build stronger primary health care and health systems resilience, the Islamic Development Bank (IsDB) announced an important grant allocation of ...
The Union Ministry of Ayush (MoA) is working closely with the World Health Organization (WHO) to develop an International Herbal Pharmacopoeia (IHP) to set global quality and efficacy standards for ...
GSK announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or disease-related symptoms, in adult patients with intermediate or high-risk primary ...
UDF proposes need for a centralized drug regulatory cadre, regulatory body in India to bolster patient safety: Shardul Nautiyal, Mumbai Thursday, November 14, 2024, 08:00 Hrs [IST ...
DCGI calls for meeting with stakeholders of cosmetics industry to discuss issues: Our Bureau, New Delhi Thursday, November 14, 2024, 08:00 Hrs [IST] The Drugs Controller General o ...
Pharma Programme, that the Pradhan Mantri Scholarship for Pharmacy Postgraduate Studies (PMSPPS) will be awarded to eligible ...
Qiagen collaborates with McGill University to advance microbiome research: Montreal, Canada Thursday, November 14, 2024, 10:00 Hrs [IST] Qiagen, a Netherlands-based leading global ...
Pharmacy college job fairs propel rapport between academia and industry to create capable workforce: Nandita Vijayasimha, Bengaluru Thursday, November 14, 2024, 08:00 Hrs [IST] Ph ...
Johnson & Johnson announced that the US Food and Drug Administration (FDA) has granted nipocalimab Breakthrough Therapy designation (BTD) for the treatment of adults living with moderate-to-severe ...